Literature DB >> 9820460

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

A S Levey1, J A Beto, B E Coronado, G Eknoyan, R N Foley, B L Kasiske, M J Klag, L U Mailloux, C L Manske, K B Meyer, P S Parfrey, M A Pfeffer, N K Wenger, P W Wilson, J T Wright.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9820460     DOI： 10.1016/s0272-6386(98)70145-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  160 in total

Review 1.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 2.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

3.  Multidisciplinary team care may slow the rate of decline in renal function.

Authors:  Elizabeth A Bayliss; Bharati Bhardwaja; Colleen Ross; Arne Beck; Diane M Lanese
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 8.237

Review 4.  Acute coronary syndromes in patients with renal failure.

Authors:  Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

5.  Beneficial effects of statins on the kidney.

Authors:  B Afzali; D J A Goldsmith
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

6.  Targeting Blood Vessel Stiffness to Protect Kidney Function.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 8.237

Review 7.  Cardiovascular risk factors following renal transplant.

Authors:  Jill Neale; Alice C Smith
Journal:  World J Transplant       Date:  2015-12-24

Review 8.  Combating diabetic nephropathy with drug therapy.

Authors:  D Martins; K Norris
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

9.  Trimethylamine-N-oxide acutely increases cardiac muscle contractility.

Authors:  Carlee I Oakley; Julian A Vallejo; Derek Wang; Mark A Gray; LeAnn M Tiede-Lewis; Tilitha Shawgo; Emmanuel Daon; George Zorn; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-03       Impact factor: 4.733

Review 10.  Ghrelin and leptin pathophysiology in chronic kidney disease.

Authors:  Sujana S Gunta; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2012-12-11       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.